Table 1.
Global revenue of Gardasil and Cervarix from 2006–2018.
Table 2.
Number of Gardasil doses sold in different countries and country groups between 2010–2017 and forecasted quantities until 2027 (middle estimates), in millions.
Table 3.
Variable costs for manufacturing Gardasil, in 2018 US$.
Table 4.
Estimated PDV of the stream of operating profits (in million 2018 US$) for the periods 2020–2028 and 2007–2028, applying Eq No. 2.
Table 5.
Annual manufacturing fixed costs, in million 2018 US$.
Table 6.
PDV of the stream of fixed manufacturing and marketing costs from 2020–2028 and 2007–2028, in million 2018 US$, applying Eq No. 3.
Table 7.
Estimated global patent buyout price in 2020 and total patent value of Gardasil (2007–2028) in million 2018 US$, applying Eq No. 4.
Table 8.
Estimated R&D costs on subjects, site and study of Gardasil-4 and Gardasil-9 (in 2018 US$).
Table 9.
Total R&D cost derivation (in 2018 US$).